Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Panel backs fund to explore psychedelic‑assisted ‘breakthrough’ therapies for veteran suicide prevention
Summary
SB 1101 would establish a fund and council to support clinical trials, training and patient access for FDA breakthrough‑designated psychedelic‑assisted therapies targeted at veterans with PTSD and treatment‑resistant conditions. The subcommittee reported the bill after supporters — including veteran advocates and medical
The subcommittee reported SB 1101, which would create a Breakthrough Therapies for Veteran Suicide Prevention fund to support clinical trials, patient access programs and training related to FDA breakthrough‑designated therapies, including MDMA‑assisted therapy for PTSD and psilocybin‑based therapies for treatment‑resistant depression.
Sponsor remarks: Sen. Hashmi said veterans have disproportionately high suicide risk and that emerging research shows some breakthrough psychedelic‑assisted therapies may…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
